Advances in Interventional Cardiology
eISSN: 1897-4295
ISSN: 1734-9338
Advances in Interventional Cardiology/Postępy w Kardiologii Interwencyjnej
Current Issue Archive Manuscripts accepted About the journal Editorial board Abstracting and indexing Subscription Contact Instructions for authors Publication charge Ethical standards and procedures
Editorial System
Submit your Manuscript
SCImago Journal & Country Rank
4/2025
vol. 21
 
Share:
Share:
Image in intervention

Mechanical thrombectomy with the Penumbra system in a patient with acute myocardial infarction

Szymon Glanowski
1
,
Gabriela Kapral
1
,
Mikołaj Derewońko
1
,
Anna Manikowska
1
,
Jacek Legutko
2
,
Paweł Kleczyński
2

  1. Students’ Scientific Group of Modern Cardiac Therapy at the Department of Interventional Cardiology, Institute of Cardiology, Jagiellonian University Medical College, Krakow, Poland
  2. Department of Interventional Cardiology, Institute of Cardiology, Jagiellonian University Medical College, St. John Paul II Hospital, Krakow, Poland
Adv Interv Cardiol 2025; 21, 4 (82): 606–607
Online publish date: 2025/11/13
Article file
Get citation
 
 

Mechanical thrombectomy (MT) has emerged as an adjunctive treatment for high-thrombus-burden lesions, particularly in cases involving highly resistant thrombi [1]. An invasive treatment of such lesions might be a therapeutic challenge for cardiologists, due to the need to achieve a hemodynamically optimal result while avoiding serious complications, such as stroke, no-reflow syndrome, or coronary artery dissection. Aspiration systems such as the Penumbra device show growing potential when they are applied in coronary artery treatment, particularly in complex cases where thrombus removal is critical for achieving optimal reperfusion, especially after failed manual aspiration [2].

A 53-year-old male patient with multimorbidity – hypertension, hyperlipidemia, type 2 diabetes, multivessel coronary disease – and a history of multiple percutaneous coronary interventions (PCIs), presenting with non-ST-elevation myocardial infarction, was admitted to the cardiology department. Coronary angiography showed total occlusion of the proximal right coronary artery (RCA) (Figure 1 A), with developed collateral circulation. Echocardiography on admission showed slightly decreased left ventricular ejection fraction (LVEF) of 45–50%.

Figure 1

A – Angiographic image of the right coronary artery (RCA) before the first stage of percutaneous coronary intervention (PCI). B – Angiographic image of the RCA after the primary PCI; large aneurysm visible (arrow). C – Intravascular ultrasound (IVUS) during the second stage of PCI. D – Angiographic image of the RCA after the mechanical thrombectomy (MT)

/f/fulltexts/PWKI/57085/PWKI-21-4-57085-g001_min.jpg

Primary PCI of the RCA with subsequent 7F manual thrombectomy (iVascular, Spain) was performed. The aspirate contained multiple fragments of thrombus. Control coronary angiography revealed a large aneurysm with a 12 mm diameter and a massive thrombus in its distal part, occluding the middle and distal segments of the RCA (Figure 1 B). Due to the clinical image and very low probability of restoring vessel patency, the patient was managed conservatively with dual antiplatelet therapy (including ticagrelor) and anticoagulation with low molecular weight heparin.

Seven days later, follow-up angiography, performed due to exertional angina, revealed total occlusion of the RCA, and another PCI, this time with an MT IndigoCath RX 6F system (Penumbra, USA), was performed under intravascular ultrasound (IVUS) guidance (Figure 1 C). Multiple passages of thrombectomy were performed with removal of abundant debris, restoring a TIMI 3 flow (Figure 1 D). Next, several balloon inflations (2.5 × 20 mm to 20 atm, 3.0 × 15 mm to 16 atm), including prolonged inflation of a drug-eluting balloon (DEB) 3.5 × 30 mm, were performed. The posterior descending branch of the RCA remained occluded, as it turned out to be a chronic total occlusion. The patient was started on further conservative treatment and discharged home in a good overall condition.

Data regarding the use of MT aspiration systems, such as the IndigoCath RX 6F, in acute coronary syndromes are relatively scarce. However, based on the available data, they appear to reduce the prevalence of post-procedural no-reflow syndrome, particularly when used as part of double protection [3]. Moreover, use of mechanical systems may result in clinically meaningful benefits, at least non-inferior to manual thrombus aspiration technique [4]. Therefore, the use of aspiration systems might become a part of a novel approach to treatment of high-thrombus-burden lesions, especially in cases involving very large thrombi or patients at high risk of no-reflow.

Ethical approval

Not applicable.

Conflict of interest

The authors declare no conflict of interest.

References

1 

Milzi A, Simonetto F, Landi A. Percutaneous revascularization of thrombotic and calcified coronary lesions. J Clin Med 2025; 14: 692.

2 

Tashtish N, Chami T, Dong T, et al. Routine use of the “Penumbra” thrombectomy device in myocardial infarction: a real-world experience-ROPUST Study. J Interv Cardiol 2022; 2022: 5692964.

3 

d’Entremont MA, Alazzoni A, Dzavik V, et al. No-reflow after primary percutaneous coronary intervention in patients with ST-elevation myocardial infarction: an angiographic core laboratory analysis of the TOTAL Trial. EuroIntervention 2023; 19: e394–401.

4 

Czyż Ł, Tekieli Ł, Mazurek A, et al. Neuro-tracking catheter technology for coronary thrombus extraction: Indigo CAT RX Continuous Aspiration System – first use in Poland. Adv Interv Cardiol 2024; 20: 206–9.

Copyright: © 2025 Termedia Sp. z o. o. This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) License (http://creativecommons.org/licenses/by-nc-sa/4.0/), allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.
 
Quick links
© 2026 Termedia Sp. z o.o.
Developed by Termedia.